- 全部删除
- 您的购物车当前为空
Pivekimab是一种靶向CD123(IL-3RA)的高亲和力的人源单克隆抗体,可用于合成ADC分子pivekimab sunirine,可用于研究急性髓性白血病和母细胞浆细胞样树突状细胞肿瘤 (BPDCN) 。
为众多的药物研发团队赋能,
让新药发现更简单!
Pivekimab是一种靶向CD123(IL-3RA)的高亲和力的人源单克隆抗体,可用于合成ADC分子pivekimab sunirine,可用于研究急性髓性白血病和母细胞浆细胞样树突状细胞肿瘤 (BPDCN) 。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,980 | In stock | |
5 mg | ¥ 7,460 | In stock | |
10 mg | ¥ 9,860 | In stock | |
25 mg | ¥ 14,900 | In stock | |
50 mg | ¥ 19,700 | In stock |
Pivekimab 相关产品
产品描述 | Pivekimab is a high-affinity humanised monoclonal antibody targeting CD123 (IL-3RA), which can be used to synthesise the ADC molecule pivekimab sunirine, for the study of acute myeloid leukaemia and blast plasmacytoid dendritic cell neoplasm (BPDCN). |
别名 | 匹维奇单抗 |
CAS No. | 2234335-84-1 |
颜色 | Transparent |
物理性状 | Liquid |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容